Clinical Laboratory Improvement Advisory Committee (CLIAC), 9807 [08-824]
Download as PDF
<![CDATA[
9807
Federal Register / Vol. 73, No. 36 / Friday, February 22, 2008 / Notices
ESTIMATED ANNUALIZED BURDEN TABLE
Type of respondent
Number of
respondents
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total burden
hours
State, local, or tribal governments, nonprofits .................................................
20
1
200
4,000
Terry Nicolosi,
Office of the Secretary, Paperwork Reduction
Act Reports Clearance Officer.
[FR Doc. E8–3294 Filed 2–21–08; 8:45 am]
BILLING CODE 4150–17–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
mstockstill on PROD1PC66 with NOTICES
Clinical Laboratory Improvement
Advisory Committee (CLIAC)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting for the
aforementioned committee:
Times and Dates:
8 a.m.–5 p.m., February 20, 2008.
8 a.m.–3:30 p.m., February 21, 2008.
Place: Centers for Disease Control and
Prevention, 1600 Clifton Road, NE.,
Tom Harkin Global Communications
Center, Building 19, Room 232,
Auditorium B, Atlanta, Georgia 30333.
Status: Open to the public, limited
only by the space available. The meeting
room accommodates approximately 100
people.
Purpose: This Committee is charged
with providing scientific and technical
advice and guidance to the Secretary of
Health and Human Services, the
Assistant Secretary for Health, and the
Director, CDC, regarding the need for,
and the nature of, revisions to the
standards under which clinical
laboratories are regulated; the impact on
medical and laboratory practice of
proposed revisions to the standards; and
the modification of the standards to
accommodate technological advances.
Matters To Be Discussed: The agenda
will include updates from the CDC, the
Centers for Medicare & Medicaid
Services, and the Food and Drug
Administration; and presentations and
discussion addressing ‘‘20 Years of
CLIA: Needs for Quality Then vs. Now;’’
evidence gathered since CLIA
implementation demonstrating the
impact of standards/accreditation on
laboratory quality; perspectives on
Quality Management System
implementation; and laboratory
VerDate Aug<31>2005
16:38 Feb 21, 2008
Jkt 214001
biosafety. Agenda items are subject to
change as priorities dictate.
Due to administrative issues that had
to be resolved, the Federal Register
notice is being published less than
fifteen days before the date of the
meeting.
Contact Person for More Information:
Nancy Anderson, Chief, Laboratory
Practice Standards Branch, Division of
Laboratory Systems, National Center for
Preparedness, Detection, and Control of
Infectious Diseases, Coordinating Center
for Infectious Diseases, CDC, 1600
Clifton Road, NE., Mailstop F–11,
Atlanta, Georgia 30333; telephone (404)
718–1025; fax (404) 718–1085; or via email at Nancy.Anderson@cdc.hhs.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both CDC
and the Agency for Toxic Substances
and Disease Registry.
Dated: February 19, 2008.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention (CDC).
[FR Doc. 08–824 Filed 2–20–08; 10:32 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–1491–N]
Medicare Program; Extension of
Certain Hospital Wage Index
Reclassifications
Centers for Medicare &
Medicaid Services (CMS) HHS.
ACTION: Notice.
AGENCY:
SUMMARY: This notice announces the
extension of the expiration date for
certain wage index geographic
reclassifications and special exceptions
as implemented by section 117 of the
Medicare, Medicaid and SCHIP
Extension Act of 2007 (Pub. L. 110–
173). Certain geographic
reclassifications and special exception
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
hospitals’ wage indices that were set to
expire on September 30, 2007 are now
extended through September 30, 2008.
In addition, for hospital reclassifications
extended by Division B, Title I, section
106(a) of the Tax Relief and Health Care
Act of 2006, Pub. L. 109–432, that
resulted in a lower wage index for the
second half of FY 2007, we will apply
the higher wage index that was
applicable to such hospitals during the
first half of FY 2007, for the entire fiscal
year.
DATES: Effective date: This notice is
effective on February 22, 2008.
Applicability date: This notice is
applicable to the hospitals identified in
section II.A. of this notice on October 1,
2007 and to the hospitals identified in
section II.B. of this notice on April 1,
2007.
FOR FURTHER INFORMATION CONTACT:
Brian Slater, (410) 786–5229.
SUPPLEMENTARY INFORMATION:
I. Background
Section 508 of the Medicare
Prescription Drug, Improvement and
Modernization Act of 2003 (MMA) (Pub.
L. 108–173) permitted a qualifying
hospital to appeal the wage index
classification otherwise applicable to
the hospital and apply for
reclassification to another area of the
State in which the hospital was located
(or, at the discretion of the Secretary, to
an area within a contiguous State).
Hospitals were required to submit their
applications by February 15, 2004. In
the February 13, 2004 Federal Register
(69 FR 7340), we published a notice that
described our implementation of section
508 of MMA. The Congress limited the
reclassifications under section 508 of
MMA to a 3-year period beginning April
1, 2004 and ending March 31, 2007.
Section 106(a) of the Medicare
Improvements and Extension Act,
Division B of the Tax Relief and Health
Care Act of 2006 (MIEA–TRHCA) (Pub.
L. 109–432) extended any geographic
reclassification that was set to expire on
March 31, 2007 by 6 months until
September 30, 2007. In the March 23,
2007 Federal Register (72 FR 13799), we
published a notice explaining how we
would implement section 106 of MIEA–
TRHCA. We also explained that for a
subset of hospitals whose
E:\FR\FM\22FEN1.SGM
22FEN1
]]>Agencies
[Federal Register Volume 73, Number 36 (Friday, February 22, 2008)]
[Notices]
[Page 9807]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 08-824]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Clinical Laboratory Improvement Advisory Committee (CLIAC)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following meeting for the aforementioned
committee:
Times and Dates:
8 a.m.-5 p.m., February 20, 2008.
8 a.m.-3:30 p.m., February 21, 2008.
Place: Centers for Disease Control and Prevention, 1600 Clifton
Road, NE., Tom Harkin Global Communications Center, Building 19, Room
232, Auditorium B, Atlanta, Georgia 30333.
Status: Open to the public, limited only by the space available.
The meeting room accommodates approximately 100 people.
Purpose: This Committee is charged with providing scientific and
technical advice and guidance to the Secretary of Health and Human
Services, the Assistant Secretary for Health, and the Director, CDC,
regarding the need for, and the nature of, revisions to the standards
under which clinical laboratories are regulated; the impact on medical
and laboratory practice of proposed revisions to the standards; and the
modification of the standards to accommodate technological advances.
Matters To Be Discussed: The agenda will include updates from the
CDC, the Centers for Medicare & Medicaid Services, and the Food and
Drug Administration; and presentations and discussion addressing ``20
Years of CLIA: Needs for Quality Then vs. Now;'' evidence gathered
since CLIA implementation demonstrating the impact of standards/
accreditation on laboratory quality; perspectives on Quality Management
System implementation; and laboratory biosafety. Agenda items are
subject to change as priorities dictate.
Due to administrative issues that had to be resolved, the Federal
Register notice is being published less than fifteen days before the
date of the meeting.
Contact Person for More Information: Nancy Anderson, Chief,
Laboratory Practice Standards Branch, Division of Laboratory Systems,
National Center for Preparedness, Detection, and Control of Infectious
Diseases, Coordinating Center for Infectious Diseases, CDC, 1600
Clifton Road, NE., Mailstop F-11, Atlanta, Georgia 30333; telephone
(404) 718-1025; fax (404) 718-1085; or via e-mail at
Nancy.Anderson@cdc.hhs.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both CDC and the Agency for Toxic Substances and Disease Registry.
Dated: February 19, 2008.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention (CDC).
[FR Doc. 08-824 Filed 2-20-08; 10:32 am]
BILLING CODE 4163-18-P
